Published in Oncol Lett on September 06, 2016
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med (1998) 3.17
ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Br J Cancer (2004) 1.88
TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis Markers (2005) 1.32
The source of APRIL up-regulation in human solid tumor lesions. J Leukoc Biol (2006) 1.11
APRIL is overexpressed in cancer: link with tumor progression. BMC Cancer (2009) 1.07
Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas. Anal Cell Pathol (Amst) (2011) 0.94
Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells. J Chemother (2013) 0.91
TGF-β1, IL-6, and TNF-α in bronchoalveolar lavage fluid: useful markers for lung cancer? Sci Rep (2014) 0.91
Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway. Toxicology (2013) 0.89
Protein kinase C-ERK1/2 signal pathway switches glucose depletion-induced necrosis to apoptosis by regulating superoxide dismutases and suppressing reactive oxygen species production in A549 lung cancer cells. J Cell Physiol (2007) 0.89
The TNF family member APRIL promotes colorectal tumorigenesis. Cell Death Differ (2012) 0.88
Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas. Eur J Cancer (2008) 0.86
Lentivirus-mediated short hairpin RNA targeting the APRIL gene suppresses the growth of pancreatic cancer cells in vitro and in vivo. Oncol Rep (2008) 0.86
Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells. Mol Cancer Res (2009) 0.84
APRIL binding to BCMA activates a JNK2-FOXO3-GADD45 pathway and induces a G2/M cell growth arrest in liver cells. J Immunol (2012) 0.84
TNF receptor-associated factor 6 in advanced non-small cell lung cancer: clinical and prognostic implications. J Cancer Res Clin Oncol (2012) 0.83
Association between TNF-α gene 308G>A polymorphism and lung cancer risk: a meta-analysis. Tumour Biol (2014) 0.82
APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer. Carcinogenesis (2015) 0.80
TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC). Rocz Akad Med Bialymst (1997) 0.79
BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis. PLoS One (2013) 0.79
A series of patients on anti-TNF therapy referred to a multidisciplinary lung cancer service. Ir J Med Sci (2012) 0.78
[The preoperative and postoperative changes of T lymphocyte subsets and TNF in patients with locally advanced lung cancer.]. Zhongguo Fei Ai Za Zhi (1999) 0.78